ChiCTR2100045116
结束
/
/
/
2021-04-07
/
/
Chronic kidney disease
Efficacy of Vitamin D Supplementation and Physical Activity in Improving Musculoskeletal Health in Individuals with Chronic Kidney Disease
Efficacy of Vitamin D Supplementation and Physical Activity in Improving Musculoskeletal Health in Individuals with Chronic Kidney Disease
Aims of the study: To assess the improvement in musculoskeletal health in individuals with chronic kidney disease having 25 OH vitamin D deficiency by giving vitamin D3 (cholecalciferol) and increased physical therapy. Primary Objectives: To compare improvement in objective measure of musculoskeletal health as assessed by hand grip measure in individuals with chronic kidney disease randomized to either vitamin D3 alone or vitamin D3 along with targeted physical therapy. To compare the improvement in physical functioning in individuals with chronic kidney disease randomized to either vitamin D3 alone or vitamin D3 along with targeted physical therapy based on subjective questionnaires. To compare differences in musculoskeletal health as measured by change in muscular strength and physical functioning in individuals with chronic kidney disease randomized to either vitamin D3 alone or vitamin D3 along with targeted physical therapy. Secondary Objectives: To assess the improvement in serum 25OH vitamin D levels among patients with Chronic Kidney disease with vitamin D3 supplementations.
随机平行对照
Ⅰ期
Randomization will be performed via computer generated random numbers by a statistician. A block randomization strategy with individual blocks with varying multiples of 4 will be used to periodically balance the assignment in the 2 study arms. Randomization lists will be stratified by Hospitals (AKUH and kidney
Not stated
None
/
18;28
/
2012-01-01
2016-12-31
/
1. Patients aged 20 to 60 years; 2. CKD stage 2-4; 3. Patients with CKD and having creatinine of >=1.7 mg/dL for men and >=1.4 mg/dL for women will be screened; 4. Vitamin D deficient subjects (<=20 nmol/L) (32); 5. Able to provide written informed consent.；
登录查看1. Patients with any transplant (due to use of immune-suppression); 2. Patients with CKD 5 or ESRD; 3. Patients receiving dialysis; 4. Patients who are under treatment for Vitamin D deficiency; 5. Patients who have some sort of known vitamin D deficiency related bone disease by history; 6. Subjects already maintained on steroids; 7. Patients Who Have Been On (25 Or 1, 25, OH Vitamin D Supplementation for Vitamin D Repletion- I/M in last One Year; 8. Patients with known chronic inflammatory disease, malignancy; 9. Subjects who cannot perform physical activity due to any disability or limiting condition; 10. Patients with known depression; 11. Patients with calcium and phosphorus product of > 70 mg/dl.；
登录查看None
/
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
医药速览2024-11-22
亚盛医药2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
